Viemed Healthcare (NASDAQ:VMD) reported quarterly earnings of $0.04 per share which missed the analyst consensus estimate of $0.07 by 42.86 percent. The company reported quarterly sales of $55.000 million which beat the analyst consensus estimate of $53.800 million by 2.23 percent. This is a 26.99 percent increase over sales of $43.311 million the same period last year.
Viemed Healthcare Q2 2024 Adj. EPS $0.04 Misses $0.07 Estimate, Sales $55.000M Beat $53.800M Estimate
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.